Suprachoroidal hemorrhage is a feared complication of all types of intraocu
lar surgery. Although rare, it is typically associated with severe visual d
isability, and this has prompted efforts to better understand the pathogene
sis of this condition, to identify the patients at risk for this event, and
to improve treatment of patients who develop this condition either intraop
eratively or postoperatively. Controversy still exists regarding the best c
ourse of treatment for these patients. Although the introduction of perfluo
rocarbon liquids as a surgical adjunct during vitrectomy surgery may assist
in the removal of suprachoroidal hemorrhage, the visual outcomes still rem
ain disappointing. (Surv Ophthalmol 43: 471-486, 1999. (C) 1999 by Elsevier
Science Inc. All rights reserved.).